• Home

  • Documents

  •  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf...
126

 · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 2:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 3:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 4:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 5:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 6:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 7:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 8:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 9:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 10:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 11:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 12:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 13:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 14:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 15:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 16:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 17:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 18:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 19:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 20:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 21:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 22:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 23:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 24:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 25:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 26:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 27:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 28:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 29:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 30:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 31:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 32:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 33:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 34:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 35:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 36:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 37:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 38:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 39:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 40:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 41:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 42:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 43:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 44:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 45:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 46:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 47:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 48:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 49:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 50:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 51:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 52:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 53:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 54:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 55:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 56:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 57:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 58:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 59:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 60:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 61:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 62:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 63:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 64:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 65:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 66:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 67:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 68:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 69:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 70:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 71:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 72:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 73:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 74:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 75:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 76:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 77:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 78:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 79:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 80:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 81:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 82:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 83:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 84:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 85:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 86:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 87:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 88:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 89:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 90:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 91:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 92:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 93:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 94:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 95:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 96:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 97:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 98:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 99:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 100:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 101:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 102:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 103:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 104:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 105:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 106:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 107:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 108:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 109:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 110:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 111:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 112:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 113:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 114:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 115:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 116:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 117:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 118:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 119:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 120:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 121:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 122:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 123:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 124:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 125:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520
Page 126:  · 2019-11-27 · abbvie 2.722-21. 2.7.2 R&D/18/0507 max Pharmacokinetic Parameter AUG AUC inf AUG AUC inf AUG AUC inf Central Value Ratio of Central Values Test 0.278 3.489 3.520

Open AUC Update CFA & Sednterp San Antonio 2012. HARDWARE Open AUC

Open AUC Update CFA & Sednterp San Antonio 2012. HARDWARE Open AUC

Documents
INF-UIT 2004 by Øystein Haugen and Ketil Stølen · 31-Aug-06 INF5150 INFUIT Haugen / Stølen 7 INF 5150 Goal: Unassailable IT-Systems The course INF-UIT aims at teaching the students

INF-UIT 2004 by Øystein Haugen and Ketil Stølen · 31-Aug-06 INF5150 INFUIT Haugen / Stølen 7 INF 5150 Goal: Unassailable IT-Systems The course INF-UIT aims at teaching the students

Documents
Certificate AUC

Certificate AUC

Documents
HTSKJRJSHJlRJUTRTlFSIlJXUJRTlUFSJQ Antimicrobial ......Echinocandins AUC 0–24 /MIC fAUC 0–24 /MIC:10–20 AUC 0–24 /MIC > 3000 a Nodata Fluconazole AUC 0–24 /MIC AUC 0–24

HTSKJRJSHJlRJUTRTlFSIlJXUJRTlUFSJQ Antimicrobial ......Echinocandins AUC 0–24 /MIC fAUC 0–24 /MIC:10–20 AUC 0–24 /MIC > 3000 a Nodata Fluconazole AUC 0–24 /MIC AUC 0–24

Documents
TION PUBLIC AUC

TION PUBLIC AUC

Documents
Semi-supervised AUC optimization based on positive ...We refer to the method minimizing the NU-AUC risk as NU-AUC optimization. 3.2 Semi-supervised AUC optimization Next, we propose

Semi-supervised AUC optimization based on positive ...We refer to the method minimizing the NU-AUC risk as NU-AUC optimization. 3.2 Semi-supervised AUC optimization Next, we propose

Documents
CAMARGO CEMETERY CAMARGO TOWNSHIP - Douglas County · CAMARGO CEMETERY CAMARGO TOWNSHIP 1. Berry, John W. Co. D 49th KY Inf. 1924 2. Bragg, Alexander Co. G 135th IL Inf. Aug. 31,

CAMARGO CEMETERY CAMARGO TOWNSHIP - Douglas County · CAMARGO CEMETERY CAMARGO TOWNSHIP 1. Berry, John W. Co. D 49th KY Inf. 1924 2. Bragg, Alexander Co. G 135th IL Inf. Aug. 31,

Documents
Auc Settlement

Auc Settlement

Documents
AUC Campus Map

AUC Campus Map

Documents
AUC Down Payment and AUC settlement.pdf

AUC Down Payment and AUC settlement.pdf

Documents
Aventura Residence - AUC Housing

Aventura Residence - AUC Housing

Documents
Lu AA21004 . .O/ocv 111 In-DTPA 5-HIAA 5-HT 5-HTT 99m Tc-DTPA ADP ALP ALT ANCOVA ANOVA aPTT AST ASEX AUC AUCœ AUCINR AUC last AUG AUCt,ss AUEC24 AUMC last AUT BDNF

Lu AA21004 . .O/ocv 111 In-DTPA 5-HIAA 5-HT 5-HTT 99m Tc-DTPA ADP ALP ALT ANCOVA ANOVA aPTT AST ASEX AUC AUCœ AUCINR AUC last AUG AUCt,ss AUEC24 AUMC last AUT BDNF

Documents
AUC Down Payment

AUC Down Payment

Documents
Avionics AUC[1]

Avionics AUC[1]

Documents
CITA- LEGAL AUC

CITA- LEGAL AUC

Documents
You trippin ’ through the auc : 10 shot candid of auc history

You trippin ’ through the auc : 10 shot candid of auc history

Documents
121i-Auc connected auc ons 121 sites in na onwide An italic font meant Nyusatsukai(Tender Auc on) *Realrobo can be applied on same connected auc on sites with i-Auc real. Kyushu Area

121i-Auc connected auc ons 121 sites in na onwide An italic font meant Nyusatsukai(Tender Auc on) *Realrobo can be applied on same connected auc on sites with i-Auc real. Kyushu Area

Documents
Auc Transcript-3

Auc Transcript-3

Documents
Registration in AUC

Registration in AUC

Documents
AMC CAMO GmbH DE.MG.1034 COMPONENT TIME … · Unequipped Blade Pin SLL INF 0,0 h 8-Aug-2007 350A31-1771-21 M20132 Unequipped Blade Pin SLL INF 0,0 h 8-Aug-2007 350A31-1771-21 M20144

AMC CAMO GmbH DE.MG.1034 COMPONENT TIME … · Unequipped Blade Pin SLL INF 0,0 h 8-Aug-2007 350A31-1771-21 M20132 Unequipped Blade Pin SLL INF 0,0 h 8-Aug-2007 350A31-1771-21 M20144

Documents
Primary nationality AUC · Endowment 2015 - 2016 Endowment value $573,670,274 ... Architectural Engineering 275 The American University in Cairo AUC Profile 2016 - 2017 MISSION AUC

Primary nationality AUC · Endowment 2015 - 2016 Endowment value $573,670,274 ... Architectural Engineering 275 The American University in Cairo AUC Profile 2016 - 2017 MISSION AUC

Documents
AUC Down Payment and AUC Settlement

AUC Down Payment and AUC Settlement

Documents
Withdrawal assessment report for Efgratin · In the single PK/PD study 74080, the PK endpoints AUC 0-tlast, AUC 0-inf and C max indicate higher systemic exposure for RGB-02 compared

Withdrawal assessment report for Efgratin · In the single PK/PD study 74080, the PK endpoints AUC 0-tlast, AUC 0-inf and C max indicate higher systemic exposure for RGB-02 compared

Documents
AUC New Cairo Campus Housing Photo Slideshowconf.aucegypt.edu/ConfAdmin/kseghir_images/AUC... · AUC New Cairo Campus Housing Photo Slideshow . Student Housing (on left), Faculty

AUC New Cairo Campus Housing Photo Slideshowconf.aucegypt.edu/ConfAdmin/kseghir_images/AUC... · AUC New Cairo Campus Housing Photo Slideshow . Student Housing (on left), Faculty

Documents
AUC down payment and AUC Settlementdocshare01.docshare.tips/files/23918/239180489.pdf · AUC Down Payment and AUC Settlement SAP COMMUNITY NETWORK SDN - sdn.sap.com | BPX - bpx.sap.com

AUC down payment and AUC Settlementdocshare01.docshare.tips/files/23918/239180489.pdf · AUC Down Payment and AUC Settlement SAP COMMUNITY NETWORK SDN - sdn.sap.com | BPX - bpx.sap.com

Documents
UN/SCETDG/48/INF€¦  · Web viewun/scetdg/48/inf.15un/sceghs/30/inf.4. un/scetdg/48/inf.15. un/sceghs/30/inf.4. un/scetdg/48/inf.15 un/sceghs/ 30 / inf. 4

UN/SCETDG/48/INF€¦  · Web viewun/scetdg/48/inf.15un/sceghs/30/inf.4. un/scetdg/48/inf.15. un/sceghs/30/inf.4. un/scetdg/48/inf.15 un/sceghs/ 30 / inf. 4

Documents
Auc 2009 Presentationsm

Auc 2009 Presentationsm

Documents
Optimizing Human Language Learningmasatohagiwara.net/files/201806_OptimizingHuman... · English Spanish French Average Team RNN Ensemble Multitask AUC AUC AUC Rank SanaLabs 0.861

Optimizing Human Language Learningmasatohagiwara.net/files/201806_OptimizingHuman... · English Spanish French Average Team RNN Ensemble Multitask AUC AUC AUC Rank SanaLabs 0.861

Documents
ANNUAL REVIEW 2015-16 - International Nepal Fellowship · 3 4 INF INF INF INF INF INF INF INF INF INF INF B D B R S M J K K Kathmandu G B INF NEPAL INF Nepal is a Christian Non-Governmental

ANNUAL REVIEW 2015-16 - International Nepal Fellowship · 3 4 INF INF INF INF INF INF INF INF INF INF INF B D B R S M J K K Kathmandu G B INF NEPAL INF Nepal is a Christian Non-Governmental

Documents
Revista AUC No. 34

Revista AUC No. 34

Documents